Alkermes PLC (United States) is listed on the Nasdaq and has a market capitalization of $7.84 billion, with shareholders equity totaling $1.86 billion.
The company employs approximately 2.245 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Alkermes PLC reported $1.75 billion in revenue, generating net income of $-351.00 Thousand.
Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of 4.21, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ALKS.